Lubna N Chaudhary1, Sijin Wen2, Jie Xiao2, Anne K Swisher3, Sobha Kurian4, Jame Abraham5. 1. Division of Hematology and Oncology, Froedtert and Medical College of Wisconsin, Milwaukee, Wisconsin, USA; and Section of Hematology and Oncology, West Virginia University, Morgantown, West Virginia, USA. lchaudhary@mcw.edu. 2. Department of Biostatistics, West Virginia University, Morgantown, West Virginia, USA. 3. Division of Physical Therapy and Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia, USA. 4. Section of Hematology and Oncology, West Virginia University, Morgantown, West Virginia, USA. 5. Section of Hematology and Oncology, West Virginia University, Morgantown, West Virginia, USA; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Authors: R Yerushalmi; B Dong; J W Chapman; P E Goss; M N Pollak; M J Burnell; M N Levine; V H C Bramwell; K I Pritchard; T J Whelan; J N Ingle; L E Shepherd; W R Parulekar; L Han; K Ding; K A Gelmon Journal: Ann Oncol Date: 2017-07-01 Impact factor: 32.976